Keywords: successful, half-year, cortecs, uk, biotechnology, company, reported
Successful Half-Year For Cortecs
Article | 12 March 1998
UK biotechnology company Cortecs reported sales of L3.9 million ($6.4million) for the six months ended December 31, 1997, a drop of 2.6%, while ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
